[Influence of packed red cell transfusions on blood selenium concentration in pediatric hemato-oncology]

J Mackenroth1, K Hölig, E Kuhlisch

  • 1Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden.

Klinische Padiatrie
|May 15, 2008
PubMed

Insights

Red cell transfusions (RCT) can help correct selenium (Se) deficiency in pediatric cancer patients. While not statistically significant, Se levels increased post-transfusion, improving deficiency in some children.

Area of Science:

  • Biochemistry and Nutritional Science
  • Pediatric Hematology-Oncology
  • Clinical Pathology

Context:

  • Selenium (Se) is crucial for antioxidant pathways, with 10% of body content in human blood.
  • Parents often inquire about Se supplementation for children undergoing cancer treatment.
  • Concerns exist regarding potential selenium toxicity in pediatric patients.

Purpose:

  • To investigate if packed red cell transfusions (RCT) contribute to selenium (Se) supply in pediatric patients with hemato-oncological diseases.
  • To determine Se concentrations in patients' blood before and after RCT.
  • To assess the impact of RCT on correcting Se deficiency in this vulnerable population.

Summary:

  • Seventy-seven percent of transfusion units contained Se within the normal adult range.
  • Patients' blood Se concentrations showed a non-significant increase post-RCT (66.2 to 70.7 microg/l).
  • Se deficiency, present in 45% of patients pre-RCT, decreased to 26% post-RCT, with correction in 4/8 patients.

Impact:

  • Red cell transfusions can partially correct selenium deficiency in pediatric cancer patients.
  • Highlights the importance of regular Se monitoring before considering supplementation due to fluctuating levels.
  • Informs clinical decisions regarding complementary therapies and nutritional support in pediatric oncology.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...